M&A deal value in healthcare, pharma hits record high in first half of 2022
2 years, 5 months ago

M&A deal value in healthcare, pharma hits record high in first half of 2022

Live Mint  

India’s healthcare and pharmaceutical sector saw hectic deal activity with the value of merger and acquisitions in the first six months of this calendar year scaling a record high and crossing the total deal value of $3.35 billion in 2021. M&A deal value in the sector touched $4.32 billion during January to June, compared to $2.02 billion in the same period last year, according to VCCEdge, the data and intelligence platform of VCCircle. The record M&A deal value in the sector was largely due to Biocon Biologics’s definitive agreement to buy Viatris Inc.’s global biosimilar portfolio for $3.34 billion in February. Private equity dealmaking in the healthcare and pharmaceuticals sector also remained quite robust as deal value shot up to $2.96 billion in the first six months of this year from $2.75 billion during July-December 2021.

India Healthcare Pharma Value Billion Deal Last Year First Half Deal Value  high  ma  equity  billion  pharma  biocon  hits  half  2022  period  record  value  deal  healthcare  sector

History of this topic

M&A Momentum and Trump Trades: Dealmakers’ Predictions for 2025
3 weeks, 1 day ago

M&A Momentum and Trump Trades: Dealmakers’ Predictions for 2025

Live Mint  

Mergers and acquisition activity rebounded in 2024, as access to cheaper financing released a pent-up demand to do deals after two down years. Many private equity firms have tried to softly test the market in 2024 to see if there was appetite for their portfolio assets, but many sales processes haven’t properly launched.” Anne Hiebler, global head of M&A, Credit …

M&A jumps 60% in Jan-Mar
8 months, 2 weeks ago

M&A jumps 60% in Jan-Mar

New Indian Express  

Merger and acquisition deal value soared by 60% to USD 19.6 billion in January-March 2024, while that of private equity experienced a slight dip, according to a PwC India report. With 455 deals amounting to USD 25.6 billion disclosed value, the first quarter of 2024 showcases a 24% rise in deal volume compared to the fourth quarter of calendar year …

India’s M&A activity in 2023 highest in almost a decade: Bain & Co.
11 months, 1 week ago

India’s M&A activity in 2023 highest in almost a decade: Bain & Co.

Live Mint  

Mergers and acquisitions in India last year surpassed volumes seen in most of the past decade, barring 2022, even as global M&A activity slowed, consultancy firm Bain & Co. said in a report. “The sustained momentum is driven by availability of attractive opportunities and assets, and heightened activity and disruption in sectors with structural tailwinds and favourable policies,” Bain & …

M&M share price trades flat after strong Q2 results; should you buy the stock?
1 year, 1 month ago

M&M share price trades flat after strong Q2 results; should you buy the stock?

Live Mint  

Mahindra & Mahindra shares traded flat on Monday after the auto major reported a decent earnings for the second quarter of FY24. The company’s automotive segment saw a healthy double-digit growth during the festive season, while the farm equipment segment’s performance was muted as its revenue fell 0.4% YoY. “While the valuation is still attractive versus peers, M&M has seen …

India’s M&A activity to remain buoyant amid global slump
1 year, 11 months ago

India’s M&A activity to remain buoyant amid global slump

Live Mint  

Bengaluru: Bucking the trend globally, merger and acquisition activity in India will continue to grow at a fast clip this year, buoyed by the availability of attractive assets and a positive sentiment as an investment destination, global consultancy firm Bain & Company has said in a report. According to data from the Reserve Bank of India, aggregate foreign direct investment …

Saraf And Partners Acts For Viatris In Its Sale Of Biosimilars Business To Biocon Biologics For US$ 3.335 Billion
2 years, 1 month ago

Saraf And Partners Acts For Viatris In Its Sale Of Biosimilars Business To Biocon Biologics For US$ 3.335 Billion

Live Law  

Global healthcare company - Viatris has, on November 29, completed the sale of its global biosimilars business to Biocon Biologics Limited, subsidiary of Biocon Limited for USD 3.335 billion for stock and cash consideration. The sale of global biosimilars business marks monumental moment to develop a future direction for Viatris that will not only unlock immediate value but will also …

Biocon arm to acquire biosimilars business of Viatris for $3.34 bn
2 years, 10 months ago

Biocon arm to acquire biosimilars business of Viatris for $3.34 bn

The Hindu  

Biocon subsidiary Biocon Biologics Ltd has entered into a definitive agreement with its partner Viatris Inc to acquire Viatris’ biosimilars business for $3.34 billion. Kiran Mazumdar Shaw, executive chairperson of Biocon Biologics on Monday said BBL has entered into an agreement with Viatris to acquire its biosimilars business for $3.34 billion, which would include cash of up to $2.34 billion …

Newer funding sources may kick-start M&A ecosystem
4 years, 9 months ago

Newer funding sources may kick-start M&A ecosystem

Live Mint  

Despite the recent headwinds facing the Indian economy and the fall in overall merger and acquisition activity, the domestic market continues to provide interesting opportunities for inorganic growth, said top executives of corporate India. M&A activity in India halved in value in 2019 from 2018, reflecting fewer billion-dollar deals, according to consulting firm PwC India. The year saw 765 deals …

Healthcare M&A deals worth ₹7,615 crore in FY19 highest in over 5 years: report
5 years, 8 months ago

Healthcare M&A deals worth ₹7,615 crore in FY19 highest in over 5 years: report

Live Mint  

Despite the stress on performance of health sector due to regulatory restrictions, the value of merger and acquisition deals in the sector jumped by a record 155% at ₹7,615 crore in FY19, a report said on Monday. The total value of M&A transactions in the hospital sector in FY19 recorded an increase of 155% amounting to ₹7,615 crore, the highest …

Discover Related